BIOGRAPHICAL SKETCH
(CAREER SUMMARY)Experienced Medical Research Scientist, trained health service manager with massive public mobilization skills, vast
in many aspects of field organization, team preparation, laboratory techniques, focused situation analyst, experienced
program implementation planner, process evaluator for Quality Control and Quality Assurance. Over ten years
experience in managing financial budgets for the NIH funded research programs, trainer with vast knowledge in
national and international public health matters and target oriented team player.
NAME
ODADA SUMBA, PETER
POSITION TITLE
Senior Research Officer
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training and residency training if applicable.)
INSTITUTION AND LOCATION (if applicable) DEGREE MM/YY FIELD OF STUDY
Kenyatta University, Nairobi, Kenya
Case Western Reserve University, Cleveland,
Ohio, USA
University of Nairobi / Kenya Medical Training
College
PhD
(Submitted)
MPH
Higher
Diploma
05/2010
05/2004
1985-1986
Geographical medicine
Epidemiology and
international health
Parasitology / medical
entomology
Kenya Medical Training College
Diploma
1978-1981
Medical laboratory
technology
A. Personal Statement
I have worked side-by-side with many research collaborators from 1981 when I started my research career.
Our ability to recruit and retain clinically relevant study participants provides a unique and valuable human
resource by which we have been able to address many specific aims in immunology, molecular epidemiology
of malaria and childhood cancer. My mid-career educational experience, first earning my MPH from Case
Western and now the completion of my PhD degree, has furthered my ability to continue human investigations
research on infectious disease pathogenesis, and more recently in the etiology of endemic BL, severe malaria
and the impact of specific micronutrients like selenium, zinc and copper in immune development. This
ecological expertise has paved the way for me to become an independent investigator and skilled administrator
of programs. My PhD dissertation research investigated nutritional deficiencies as a risk factor for endemic BL
by reducing the ability of the body to protect itself against malaria disease and increased EBV loads paving
way for pro-oxidant by free radicals like reactive oxygen species which have been identified in many disease
pathogenesis. As a collaborator in many projects with senior colleagues from the USA and locally, I have been
mentored in a number of laboratory and field based research and publications. My lecturing career in the
universities is focused on environmental pollution, community health and molecular epidemiology.
Specific duties.
Work closely with the Centre directors, and other heads of departments and programs.
Monitor and evaluate Kenyan sites considered for work expansion
Coordinate the training of personnel in all aspects of Total Quality Management and international
quality standards.
Develop Quality Assurance Manual and quality plans for various projects.
Conducts on-site inspections of the field activities using detailed checklists to record observations
Provide technical guidance on management and execution of research projects,
coordinate and maintain all a cross studies and study-specific documentation
Collaborate with team members on the development of research protocols, manuscripts, and regulatory
submissions to Institutional Review Boards and international funding organizations.
Ensure compliance of assigned study standard operation procedures (SOPs), Good Clinical practice
(GCP), NIH and FDA policies
Coordinates site visits with inspection staff which may be assigned by various government/private
agencies to participate in the inspection process
Prepares various reports as required by Principle investigators and institutional managements
Develop SOPs and periodical quality records.
Evaluate staff competency.
Participate in quality planning and improvement.
Part time lecturer in epidemiology, environmental toxicology and clinical nutrition epidemiology at
Maseno university Public health, and Biomedical departments.
B. Positions and Honors
Positions and Employment
1981-1985
Assistant
Lecturer,
Medical
Laboratory, Nakuru MTC, Ministry of Health, Kenya
1986-2005
Senior
Laboratory
Technologist, CVBCR, KEMRI, Kenya
2004-Present
Part-time Lecturer and chief external examiner faculty of Med.laboratory. Kenya Medical
Training College, Kisumu, Kenya
2005-Present
Senior Research Officer, CVBCR, KEMRI, Kenya
2005- todate
Part-time Lecturer / Examiner Maseno University, Kenya
Other Experience and Professional Memberships
1980-1981
Chairman, Student Representative Council (SRC), Kenya
1995-1996
Chairman, Kisumu district and Nyanza National Representative, Association of Kenya Medical
Laboratory Scientific Officers
2006
Member, KEMRI Intellectual (IP) Management Committee
Member, American Association of Public Health
Member, Association of Kenya Medical Laboratory Scientific Officers
Member, American Society of Tropical Medicine and Hygiene (ASMTH)
Member, African Organization for Research and Training in Cancer (AORTIC)
African Organization for Research and Training in Cancer (AORTIC) International conference on cancer,
Dar es Salaam, Tanzania, November 2009
African Organization for Research and Training in Cancer (AORTIC) International conference on
Burkitt’s lymphoma, Kampala, Uganda, February 2008
American Society of Tropical medicine and hygiene November 2007, Philadelphia, USA
MIM conference in Yaoundé, Cameroon 12/11- 20/11/05
The 51
stannual conference of the American Society of Tropical Medicine and Hygiene, Denver,
Colorado, USA 10-14, 2002
New systems for Predicting and Detecting Malaria Epidemics in the East African Highlands
inter-Countries workshop llMAL 14-16 Feb, 2002 , Kisumu, Kenya.
International association of Medical Laboratory technologists August 1986 Stockholm, Sweden,
KEMRI/ KETRI’ seminars and conferences from 1986
Honors
1986
Best Academic Student in Parasitology and Medical Entomology, MTC, Kenya
2003-2004
Graduate Student Senator, Case Western Reserve University (CWRU), USA
2004
CWRU Outstanding Student in Master of Public Health
2010 Appointed editorial committee member of international Journal of environmental science and
Public health
Publication in press: (British journal of cancer)
Manuscript: EP/2010/1098
Title: Microgeographic variations in Burkitt lymphoma incidence correlate with differences in malnutrition,
malaria and Epstein-Barr virus
PO Sumba
1, 2,
EW Kabiru
2,
E Namuyenga
1,3,
N Fiore
4,
RO Otieno
1,3, AM Moormann
5, AS Orago
6, PF
Rosenbaum
4,
and
R Rochford
41
Kenya Medical Research Institute, Kisumu, Kenya;
2Kenyatta University P.O. Box 43844-00100 Nairobi, Kenya;
3Department of Zoology, Maseno University, Private Bag-40105, Maseno University, Maseno, Kenya;
4Department of
Microbiology and Immunology, 750 East Adams St., SUNY Upstate Medical University, Syracuse, NY, USA 13066,
5Department of Pediatrics, University of Massachusetts Medical School - Biotech II, 373 Plantation Street, Suite 318,
Worcester, MA 01605;
6Kenya National AIDS Control Council, Argwings Kodhek Road. P.O. Box 61307 - 00200
Nairobi, Kenya.
Correspondence: Peter Odada Sumba, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya,
E-mail;
C. Selected Peer-reviewed Publications
Most relevant to the current application
1. Oloo AJ, Mudegu JV, Ngare DK, Ogutu RO, Ondijo SO,
Odada PS
, Adungo NI, Githeko AK, Ekisa WS,
Mahadevan S. The effect of permethrin impregnated sisal curtains on vector density and malaria
incidence: a pilot study. East Afr Med J. 1993 Aug;70(8):475-7.
2. Githeko AK, Adungo NI, Karanja DM, Hawley WA, Vulule JM, Seroney IK, Ofulla AV, Atieli FK, Ondijo SO,
Genga IO,
Odada PK
, Situbi PA, Oloo JA. Some observations on the biting behavior of Anopheles
gambiae s.s., Anopheles arabiensis, and Anopheles funestus and their implications for malaria control.
Exp Parasitol. 1996 Apr;82(3):306-15.
3. Karanja DM, Alaii J, Abok K, Adungo NI, Githeko AK, Seroney I, Vulule JM,
Odada P
, Oloo JA.
Knowledge and attitudes to malaria control and acceptability of permethrin impregnated sisal curtains.
East Afr Med J. 1999 Jan;76(1):42-6.
4. John
CC,
Sumba PO
, Ouma JH, Nahlen BL, King CL, Kazura JW. Cytokine responses to Plasmodium
falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect Immun. 2000
Sep;68(9):5198-204.
PMCID: PMC101778
.
5. John CC, Ouma JH,
Sumba PO
, Hollingdale MR, Kazura JW, King CL. Lymphocyte proliferation and
antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with
seasonal variation in malaria transmission. Am J Trop Med Hyg. 2002 Apr;66(4):372-8.
6. MacNeil
A,
Sumba OP
, Lutzke ML, Moormann A, Rochford R. Activation of the Epstein-Barr virus lytic
cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer. 2003 May 19;88(10):1566-9.
PMCID:
PMC2377104
.
7. John CC, Zickafoose JS,
Sumba PO
, King CL, Kazura JW. Antibodies to the Plasmodium falciparum
antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1
vary by ages of subjects and by season in a highland area of Kenya. Infect Immun. 2003
Aug;71(8):4320-5.
PMCID: PMC166050
.
8. Moormann AM, Embury PE, Opondo J,
Sumba OP
, Ouma JH, Kazura JW, John CC. Frequencies of
sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland
malaria-endemic areas of Kenya. Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):513-4.
9. Chelimo
K,
Sumba PO
, Kazura JW, Ofula AV, John CC. Interferon-gamma responses to Plasmodium
falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria
holoendemic area of western Kenya. Malar J. 2003 Nov 5;2(1):37.
PMCID: PMC280688
.
10. Cao K, Moormann AM, Lyke KE, Masaberg C,
Sumba OP
, Doumbo OK, Koech D, Lancaster A, Nelson M,
Meyer D, Single R, Hartzman RJ, Plowe CV, Kazura J, Mann DL, Sztein MB, Thomson G,
Fernández-Viña MA. Differentiation between African populations is evidenced by the diversity of alleles and
haplotypes of HLA class I loci. Tissue Antigens. 2004 Apr;63(4):293-325.
11. John CC, O'Donnell RA,
Sumba PO
, Moormann AM, de Koning-Ward TF, King CL, Kazura JW, Crabb BS.
Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface
protein-1 (MSP-protein-1 protein-19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals
in a malaria endemic area of Africa. J Immunol. 2004 Jul 1;173(1):666-72.
12. John CC, Koech DK,
Sumba PO
, Ouma JH. Risk of Plasmodium falciparum infection during a malaria
epidemic in highland Kenya, 1997. Acta Trop. 2004 Sep;92(1):55-61.
13. John CC, Moormann AM,
Sumba PO
, Ofulla AV, Pregibon DC, Kazura JW. Gamma interferon responses
to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their
relationship to age, transmission intensity, and protection against malaria. Infect Immun. 2004
Sep;72(9):5135-42.
PMCID: PMC517451
.
14. Moormann AM, Chelimo K,
Sumba OP
, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R.
Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis.
2005 Apr 15;191(8):1233-8.
15. Ofulla AV, Moormann AM, Embury PE, Kazura JW,
Sumba PO
, John CC. Age-related differences in the
detection of Plasmodium falciparum infection by PCR and microscopy, in an area of Kenya with
holo-endemic malaria. Ann Trop Med Parasitol. 2005 Jun;99(4):431-5.
16. John CC, Moormann AM, Pregibon DC,
Sumba PO
, McHugh MM, Narum DL, Lanar DE, Schluchter MD,
Kazura JW. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum
antigens and protection from infection. Am J Trop Med Hyg. 2005 Jul;73(1):222-8.
17. John CC, McHugh MM, Moormann AM,
Sumba PO
, Ofulla AV. Low prevalence of Plasmodium falciparum
infection among asymptomatic individuals in a highland area of Kenya. Trans R Soc Trop Med Hyg. 2005
Oct;99(10):780-6.
18. Moormann AM, John CC,
Sumba PO
, Tisch D, Embury P, Kazura JW. Stability of interferon-gamma and
interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related
adhesive protein in residents of a malaria holoendemic area. Am J Trop Med Hyg. 2006 Apr;74(4):585-90.
19. Githeko AK, Ayisi JM,
Odada PK
, Atieli FK, Ndenga BA, Githure JI, Yan G. Topography and malaria
transmission heterogeneity in western Kenya highlands: prospects for focal vector control. Malar J. 2006
Nov 10;5:107.
PMCID: PMC1654174
.
20. Rainey JJ, Omenah D,
Sumba PO
, Moormann AM, Rochford R, Wilson ML. Spatial clustering of endemic
Burkitt's lymphoma in high-risk regions of Kenya. Int J Cancer. 2007 Jan 1;120(1):121-7.
21. Moormann AM, Chelimo K,
Sumba PO
, Tisch DJ, Rochford R, Kazura JW. Exposure to holoendemic
malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
J Infect Dis. 2007 Mar 15;195(6):799-808.
22. John CC, Tande AJ, Moormann AM,
Sumba PO
, Lanar DE, Min XM, Kazura JW. Antibodies to
pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis.
2008 Feb 15;197(4):519-26.
PMCID: PMC2607240
.
23. Rainey JJ, Rochford R,
Sumba PO
, Kowuor D, Wilson ML, Moormann AM. Family environment is
associated with endemic Burkitt lymphoma: a population-based case-control study. Am J Trop Med Hyg.
2008 Feb;78(2):338-43.
24.
Sumba PO
, Wong SL, Kanzaria HK, Johnson KA, John CC. Malaria treatment-seeking behaviour and
recovery from malaria in a highland area of Kenya. Malar J. 2008 Nov 26;7:245.
PMCID: PMC2607295
.
25. Piriou E, Kimmel R, Chelimo K, Middeldorp JM,
Odada PS
, Ploutz-Snyder R, Moormann AM, Rochford R.
Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic
malaria region of Kenya. J Med Virol. 2009 Jun;81(6):1088-93.
PMCID: PMC Journal-In Process
.
26. Dent AE, Chelimo K,
Sumba PO
, Spring MD, Crabb BS, Moormann AM, Tisch DJ, Kazura JW. Temporal
stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults. Malar J. 2009 Jul
16;8:162.
PMCID: PMC2719655
.
27. Moormann AM,
Sumba PO
, Tisch DJ, Embury P, King CH, Kazura JW, John CC. Stability of
interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and
thrombospondin-related adhesive protein immunodominant epitopes in a highland population from
Western Kenya. Am J Trop Med Hyg. 2009 Sep;81(3):489-95.
PMCID: PMC Journal-In Process
.
28. Ernst KC, Lindblade KA, Koech D,
Sumba PO
, Kuwuor DO, John CC, Wilson ML. Environmental,
socio-demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a
case-control study. Trop Med Int Health. 2009 Oct;14(10):1258-65.
PMCID: PMC Journal-In Process
.
,D. Research Support
Ongoing Research Support
5R01
CA10267-05
Rochford
(PI)
07/01/05-04/30/10
National Cancer Institute
Effects of malaria on EBV persistence in children
Role: Co-Investigator
A multi-step model for the development of eBL was proposed in the 1980’s but little experimental data is
available to support this hypothesis. In this model, early infection of children with EBV and subsequent bouts
of malaria would suppress the EBV specific cytotoxic T cell (CTL) function and impair the host’s ability to
control the growth and expansion of the latently infected B-cells. The higher frequency of EBV-infected B cells
would increase the chance for emergence of a B-cell that had the c-myc translocation characteristics of eBL.
Therefore, this model predicts that there will be increases in the numbers of latently infected B cells in children
that are continually exposed to malaria infections. With recent development of technologies that allow
PCR-based quantitation of viral load in peripheral blood and the increased knowledge of EBV persistence in health
adults based on these methods, the time is right to revisit this long-standing hypothesis with direct
experimental data and to determine if malaria infection modulates EBV latency in children. Understanding the
persistence of the oncogenic virus EBV in this context of early primary infection and holoendemic malaria will
5R03
TW007821-02
Rochford
(PI)
04/01/08-03/31/11
Fogarty International Center
Micronutrient malnutrition and EBV persistence in children
Endemic Burkitt's lymphoma (BL) is the most common childhood cancer in low-lying humid regions of
Equatorial Africa. In Kenya, the cancer is endemic in Nyanza Province. Within Nyanza Province, we have
identified high risk and low risk clusters of BL. Two known co-factors for BL have been identified: holoendemic
malaria and EBV infection. Holoendemic malaria transmission occurs throughout Nyanza Province and
infection with EBV is not geographically restricted. This suggests that other co-factors in addition to EBV and
holoendemic malaria increase the risk for BL resulting in the high-risk clusters of BL. Several lines of evidence
suggest that another potential cofactor is micronutrient deficiency such as selenium. Selenium deficiency is
associated with several types of cancer and selenium supplementation is chemopreventative for reducing
cancer risks. We hypothesize that selenium deficiency occurs in the high BL risk area compared to the low BL
risk area and thus could be an additional co-factor increasing the risk for BL. Furthermore, we hypothesize that
selenium deficiency results in increased EBV viral load. In this proposal we will test these hypotheses by
completing the following aims: determine selenium levels in children living in regions with low and high risk for
BL and determine if reduced selenium levels correlate with elevated EBV viral load in children. We will perform
a cross-sectional analysis of children living within two high-BL risk regions and two low-BL risk regions we
identified in Nyanza Province. This proposal builds on our ongoing research projects in Kenya and the long-
standing collaboration between the two co-investigators, one at SUNY Upstate and one at the Kenya Medical
Research Institute (KEMRI). As an outcome of the proposed investigations, we expect to determine how
selenium deficiencies correlate with 2 known co-factors, EBV and malaria, in a cohort of children at risk for
developing BL. This knowledge is critical to determining the etiology of BL and ultimately, to prevent BL. This
research will be done primarily in Kisumu, Kenya at the Center for Vector Biology Research and Control,
Kenya Medical Research Institute in collaboration with P. Odada Sumba, as an extension of NIH grant
#R01CA102667. Public Health Relevance: Burkitt's lymphoma remains the most common childhood
malignancy in Equatorial Africa. We are studying what causes this cancer and why it is so common in children.
We are testing the hypothesis that essential micronutrients are deficient in children that are living in a region in
Kenya where there is a high risk for getting Burkitt's lymphoma.
Role: Co-Investigator
Completed Research Support
NIH/NIAID
5-U01-AI43906 JW
Kazura
(PI) 09/30/98-03/31/04
Immunologic Memory to Pre-erythrocytic P. falciparum
Role: Co-Investigator
NIH/NIAID
K08-AI51565
Moormann
(PI) 08/01/02-04/30/07
Immunologic Studies of Endemic Burkitt’s Lymphoma
Role: Co-investigator
FIC/NIH 1D43TW006576
CH
King
(PI)
09/05/03-03/31/08
CWRU-Kenya Infectious Diseases Research Training Program
Role: Trainee for MPH and PhD,
NIH/NIAID
1 R01-AI43906-09
JW Kazura (PI)
04/01/04-03/31/09
Human Immunity to MSP-1 in Western Kenya